Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac Damage

Università degli Studi dell'Insubria100 enrolled

Overview

To assess in moderate to severe Obstructive Sleep Apnea the effects of one year therapy with nighttime continuous positive airway pressure ventilation on the prevalence of metabolic syndrome and cardiovascular damage.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Sleep Apnea Syndrome Metabolic Syndrome Cardiac Remodelling Continuous Positive Airway Pressure Ventilation

Interventions

continuous positive airway pressure ventilationDEVICE

nighttime

dietary and life style recommendationsBEHAVIORAL

Eligibility

Sex: ALLMin age: 25 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * moderate to severe sleep apnea syndrome Exclusion Criteria: * cardiovascular diseases (coronary artery disease, stroke, peripheral artery disease) * thyroid diseases * diabetes

Locations (1)

University of Insubria-Department of Clinical Medicine

Varese, Italy

RECRUITING

Outcomes

Primary Outcomes

metabolic syndrome

Time frame: one year

left ventricular mass

Time frame: one year

diastolic function

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.